NasdaqCM - Delayed Quote USD
Verastem, Inc. (VSTM)
5.60
-0.28
(-4.76%)
At close: June 13 at 4:00:01 PM EDT
5.77
+0.17
+(3.04%)
After hours: June 13 at 7:45:33 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 502,647 | 14 |
| Sales | 83,148 | 14 |
| Net Shares Purchased (Sold) | 419,499 | 28 |
| Total Insider Shares Held | 386.84k | -- |
| % Net Shares Purchased (Sold) | -1,274.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| JOHNSON JOHN H. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| KAUFFMAN MICHAEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| ROWINSKY ERIC K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| GAGNON ROBERT E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| STUGLIK BRIAN M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| KAPUR ANIL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| ROBERTSON MICHELLE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| BUNN PAUL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| TOLLEFSON KARIN ANNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 8.13 per share. | Direct | 477,044 | May 20, 2025 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 8.13 per share. | Direct | 90,593 | May 20, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2025 |
| CALKINS DANIEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 7.30 per share. | Direct | 5,986 | May 5, 2025 |
| ROS MATTHEW Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2025 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 6.89 - 7.04 per share. | Direct | 631 | Mar 24, 2025 |
| GAGNON ROBERT E Director | Sale at price 6.95 per share. | Direct | 1,974 | Mar 17, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 6.95 per share. | Direct | 1,696 | Mar 17, 2025 |
| STUGLIK BRIAN M Director | Sale at price 6.95 per share. | Direct | 4,121 | Mar 17, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 5.70 per share. | Direct | 4,891 | Feb 4, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 5.24 per share. | Direct | 44,896 | Jan 13, 2025 |
| PATERSON DANIEL W Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| CALKINS DANIEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 6.94 per share. | Direct | 42 | Jan 6, 2025 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 3.91 - 4.34 per share. | Direct | 392 | Dec 24, 2024 |
| GAGNON ROBERT E Director | Sale at price 4.37 - 4.54 per share. | Direct | 1,862 | Dec 19, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 4.37 - 4.54 per share. | Direct | 1,907 | Dec 19, 2024 |
| STUGLIK BRIAN M Director | Sale at price 4.37 - 4.54 per share. | Direct | 4,161 | Dec 19, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 3.84 per share. | Direct | 3,118 | Nov 5, 2024 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 2.86 per share. | Direct | 17 | Oct 7, 2024 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 2.68 - 2.80 per share. | Direct | 257 | Sep 24, 2024 |
| GAGNON ROBERT E Director | Sale at price 2.79 per share. | Direct | 365 | Sep 19, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 2.79 per share. | Direct | 513 | Sep 19, 2024 |
| STUGLIK BRIAN M Director | Sale at price 2.79 per share. | Direct | 937 | Sep 19, 2024 |
| GAGNON ROBERT E Director | Sale at price 2.80 per share. | Direct | 804 | Sep 16, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 2.80 per share. | Direct | 689 | Sep 16, 2024 |
| STUGLIK BRIAN M Director | Sale at price 2.80 per share. | Direct | 1,680 | Sep 16, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 2.16 per share. | Direct | 7,009 | Aug 5, 2024 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 2.62 per share. | Direct | 18 | Jul 9, 2024 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 3.15 per share. | Direct | 88 | Jun 24, 2024 |
| GAGNON ROBERT E Director | Sale at price 3.21 - 3.49 per share. | Direct | 1,408 | Jun 20, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Sale at price 3.21 - 3.49 per share. | Direct | 1,439 | Jun 20, 2024 |
| STUGLIK BRIAN M Director | Sale at price 3.21 - 3.49 per share. | Direct | 3,145 | Jun 20, 2024 |
| CALKINS DANIEL Chief Financial Officer | Sale at price 3.16 per share. | Direct | 212 | Jun 20, 2024 |
| JOHNSON JOHN H. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| KAUFFMAN MICHAEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| ROWINSKY ERIC K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| GAGNON ROBERT E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| PATERSON DANIEL W Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| STUGLIK BRIAN M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
Related Tickers
KALV KalVista Pharmaceuticals, Inc.
12.96
-0.99%
NUVB Nuvation Bio Inc.
1.7300
-4.42%
CRDF Cardiff Oncology, Inc.
3.8100
+0.53%
ABEO Abeona Therapeutics Inc.
6.16
-1.36%
REPL Replimune Group, Inc.
9.78
-1.06%
ATRA Atara Biotherapeutics, Inc.
8.82
+1.26%
ANNX Annexon, Inc.
2.4900
-8.12%
URGN UroGen Pharma Ltd.
12.03
+8.57%
RLAY Relay Therapeutics, Inc.
3.2200
-6.67%
KPTI Karyopharm Therapeutics Inc.
4.3900
+0.69%